We are high professional team with great experience in R&D and innovative business development:
Zemskova Marina - Chief Sciense Officer. Ph.D. Biology.
Areas of interest: Translational research; Signal transduction; Molecular and cellular proteomics; Molecular biology/genomics based drug discovery; Small molecule therapeutics; Tumor microenvironment; Biomarkers discovery.
Member of American Association for Cancer Research (AACR);
Member of Tumor Microenvironment Working Group.
Keshelava Varlam - Development Adviser. Ph.D. Biology.
Intellectual property specialist.
Former managing director and main expert of 'Sygma' (venture company).
15 innovative projects were successfully launched under his management.
Total investment over $200MM.
Sorokin Konstantin - CEO.
Education: Physical Department, Moscow State University.
Master of Business Administration.
Over 5 years experience in managing innovative projects.
Bortnik's Fund expert (R&D and business development).
Central Russian Economic Forum's expert (innovations, start-ups).